Yumanity Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Kineta

13/05/2022 24:01

* Yumanity Therapeutics Inc  YMTX.OQ  reported a quarterly
adjusted loss of 88 cents​​ per share for the quarter ended in
March. The mean expectation of two analysts for the quarter was
for a loss of 95 cents per share.
    * Revenue fell 71% to $1.02 million from a year ago; 
analysts
expected $2.00 million. 
    * Yumanity Therapeutics Inc's reported EPS for the quarter
was a
loss of $1.24​.
    * The mean earnings estimate of analysts had risen by
about 12.4%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Yumanity Therapeutics Inc shares had fallen by 30.7% this
quarter and lost 64.9% so far this year.
    * The company reported a quarterly loss of $13.38 million.
    * Wall Street's median 12-month price target for Yumanity
Therapeutics Inc is $35.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 12 at 11:00 p.m.  ​All
figures in US dollars unless otherwise stated